Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 1 | 0 | 22 | 381↑1612.9% | 87↓77.1% |
| Gross Profit | -24 | 0 | 19 | 355↑1747.2% | 45↓87.3% |
| Operating Income | -39 | -83↓112.0% | -201↓143.5% | 39↑119.3% | -315↓911.1% |
| Net Income | -42 | -88↓108.0% | -198↓125.6% | 49↑124.8% | -302↓712.4% |
| EBITDA | -39 | -83↓111.9% | -201↓143.1% | 40↑119.9% | -291↓829.4% |
| EPS Diluted | -0.79 | -1.52↓92.4% | -2.98↓96.1% | 0.70↑123.5% | -4.43↓732.9% |